Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.211ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.211ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.211ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.211NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.474ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.474ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.474ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.474NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.297ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.297ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.297ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.297NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AH.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AH.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AH.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AH.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.280ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.280ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.280ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.280NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.597ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.597ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.597ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.597NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.45ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.45NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.72ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.72ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.72ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.72NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.43ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.43NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.85ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.85ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.85ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.85NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.66 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.66 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.66 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.66 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.72 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.72 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used